KATHERINE WHITE: Open Payments
NPI 1265195630 · COLQUITT, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 9 payments from 8 companies in 2025. Trend: 2023 $238 · 2024 $248 · 2025 $274
Food & beverage: $274
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 1 | $115 |
| Organogenesis Inc. | 2 | $35 |
| Kowa Pharmaceuticals America, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Averitas Pharma Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
Products named: Korlym, ZORYVE, Auvelity, QUTENZA, VIA MATRIX, AIRSUPRA, Ozempic, VRAYLAR.
Industry payments across GA — which companies pay providers there.
